Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 24,608	$ 46,019
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	28,428	27,566
Amortization of debt issuance costs	313	252
Provision for doubtful accounts	3,077	3,199
Share-based compensation	4,097	4,906
Deferred income taxes	(1,748)	1,132
Change in fair value of contingent consideration	6,266	11,535
Contingent consideration payments excess	(3,050)	(10,190)
Finance lease interest	64	0
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	11,842	40,530
Inventories	15,656	(169,031)
Prepaid expenses and other assets	(15,957)	10,116
Other non-current assets	428	413
Accounts payable	62,553	25,138
Accrued expenses and other liabilities	17,153	(4,082)
Income taxes payable	(3,647)	(12,050)
Net cash provided by (used in) operating activities	150,083	(24,547)
Cash flows from investing activities:
Capital expenditures	(6,617)	(10,977)
Cash paid for business acquisitions, net of cash acquired	(48,921)	(32,161)
Net cash used in investing activities	(55,538)	(43,138)
Cash flows from financing activities:
Borrowings on revolving credit	1,670,227	1,602,568
Repayments on revolving credit	(1,701,494)	(1,503,654)
Repayments on short-term borrowings, net	(4,384)	0
Repayments on long-term debt	(3,147)	(330)
Repayments of finance lease obligations	(660)
Repayments of finance lease obligations		(495)
Contingent consideration payments	(35,481)	(35,606)
Exercise and issuance of equity awards	754	1,509
Taxes paid on settlement of equity awards	(1,354)	(1,406)
Repurchase of common stock	(6,077)	(308)
Net cash (used in) provided by financing activities	(81,616)	62,278
Effect of exchange rate changes on cash and cash equivalents	(2,151)	277
Increase (decrease) in cash and cash equivalents	10,778	(5,130)
Cash and cash equivalents at beginning of period	23,818	25,530
Cash and cash equivalents at end of period	$ 34,596	$ 20,400